ES2575143T3 - Inhibidores de tienopiridina de la proteína quinasa C atípica - Google Patents
Inhibidores de tienopiridina de la proteína quinasa C atípica Download PDFInfo
- Publication number
- ES2575143T3 ES2575143T3 ES12795969.0T ES12795969T ES2575143T3 ES 2575143 T3 ES2575143 T3 ES 2575143T3 ES 12795969 T ES12795969 T ES 12795969T ES 2575143 T3 ES2575143 T3 ES 2575143T3
- Authority
- ES
- Spain
- Prior art keywords
- optionally substituted
- nr22r23
- members
- heterocycloalkyl
- 6alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161563310P | 2011-11-23 | 2011-11-23 | |
| US201161563310P | 2011-11-23 | ||
| PCT/US2012/065831 WO2013078126A1 (en) | 2011-11-23 | 2012-11-19 | Thienopyrimidine inhibitors of atypical protein kinase c |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2575143T3 true ES2575143T3 (es) | 2016-06-24 |
Family
ID=47295200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12795969.0T Active ES2575143T3 (es) | 2011-11-23 | 2012-11-19 | Inhibidores de tienopiridina de la proteína quinasa C atípica |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9604994B2 (https=) |
| EP (2) | EP2782917B1 (https=) |
| JP (1) | JP6206926B2 (https=) |
| CN (1) | CN104053661B (https=) |
| AU (2) | AU2012340869B2 (https=) |
| CA (1) | CA2855446C (https=) |
| ES (1) | ES2575143T3 (https=) |
| IL (1) | IL232559B (https=) |
| IN (1) | IN2014CN04558A (https=) |
| MX (1) | MX355088B (https=) |
| WO (1) | WO2013078126A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8703941B2 (en) | 2011-01-10 | 2014-04-22 | Nimbus Iris, Inc. | IRAK inhibitors and uses thereof |
| CN104582705A (zh) * | 2012-01-10 | 2015-04-29 | 林伯士艾瑞斯公司 | 白介素-1受体相关激酶(irak)抑制剂和其用途 |
| HK1210696A1 (en) | 2012-07-11 | 2016-05-06 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| WO2014011906A2 (en) | 2012-07-11 | 2014-01-16 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| JP2016505012A (ja) | 2013-01-10 | 2016-02-18 | ニンバス アイリス， インコーポレイテッド | Ｉｒａｋ阻害剤およびその使用 |
| BR112016006319A2 (pt) | 2013-09-27 | 2017-08-01 | Nimbus Iris Inc | inibidores de irak e usos dos mesmos |
| TWI675836B (zh) * | 2014-03-25 | 2019-11-01 | 美商伊格尼塔公司 | 非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑 |
| JP7114076B2 (ja) * | 2015-12-22 | 2022-08-08 | シャイ・セラピューティクス・エルエルシー | がん及び炎症性疾患の処置のための化合物 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| KR20180075228A (ko) * | 2016-12-26 | 2018-07-04 | 한미약품 주식회사 | 싸이에노피리미딘 화합물의 신규 제조방법 및 중간체 |
| JP7514005B2 (ja) | 2017-06-21 | 2024-07-10 | シャイ・セラピューティクス・エルエルシー | がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのｒａｓスーパーファミリーと相互作用する化合物 |
| WO2019119206A1 (en) * | 2017-12-18 | 2019-06-27 | Merck Sharp & Dohme Corp. | Purine inhibitors of human phosphatidylinositol 3-kinase delta |
| CN108658999B (zh) * | 2018-04-24 | 2021-02-05 | 温州大学 | 2-苯基杂环并[2,3-d]嘧啶-4(3H)-酮类化合物的合成方法 |
| EP3632908A1 (en) | 2018-10-02 | 2020-04-08 | Inventiva | Inhibitors of the yap/taz-tead interaction and their use in the treatment of cancer |
| JP7629200B2 (ja) * | 2018-11-20 | 2025-02-13 | ジョージタウン ユニバーシティ | 神経変性、筋変性及びリソソーム蓄積障害を治療するための組成物及び方法 |
| JP7407461B2 (ja) | 2018-12-19 | 2024-01-04 | シャイ・セラピューティクス・エルエルシー | がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物 |
| EP3725788A1 (en) | 2019-04-15 | 2020-10-21 | Bayer AG | Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides |
| CN116410205B (zh) * | 2021-12-29 | 2024-07-05 | 上海皓元生物医药科技有限公司 | 一种3-取代-9-甲基-噻吩并三唑并噁嗪类化合物的制备方法 |
| CN116925098B (zh) * | 2022-04-09 | 2026-02-17 | 深圳湾实验室 | 靶向泛素特异性蛋白酶1(usp1)的小分子抑制剂及其应用 |
| WO2025085725A1 (en) * | 2023-10-20 | 2025-04-24 | Scorpion Therapeutics, Inc. | Methods for treating a p53-associated cancer |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA782648B (en) | 1977-05-23 | 1979-06-27 | Ici Australia Ltd | The prevention,control or eradication of infestations of ixodid ticks |
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| JP2000038350A (ja) | 1998-05-18 | 2000-02-08 | Yoshitomi Pharmaceut Ind Ltd | 糖尿病治療薬 |
| TW564247B (en) | 1999-04-08 | 2003-12-01 | Akzo Nobel Nv | Bicyclic heteraromatic compound |
| IL148903A0 (en) | 1999-09-30 | 2002-09-12 | Neurogen Corp | Certain alkylene diamine-substituted heterocycles |
| CN1186324C (zh) | 2000-04-27 | 2005-01-26 | 山之内制药株式会社 | 稠合杂芳基衍生物 |
| US6608053B2 (en) | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| KR20030034232A (ko) | 2000-09-29 | 2003-05-01 | 닛뽕소다 가부시키가이샤 | 티에노피리미딘 화합물 및 그 염 및 제조방법 |
| AU2002336462A1 (en) | 2001-09-06 | 2003-03-24 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
| DE60236322D1 (de) | 2001-12-07 | 2010-06-17 | Vertex Pharma | Verbindungen auf pyrimidin-basis als gsk-3-hemmer |
| WO2004017950A2 (en) | 2002-08-22 | 2004-03-04 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| TW200410975A (en) | 2002-09-26 | 2004-07-01 | Nihon Nohyaku Co Ltd | New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it |
| ES2217956B1 (es) | 2003-01-23 | 2006-04-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo. |
| PL1641803T6 (pl) | 2003-06-11 | 2011-04-29 | Xention Ltd | Pochodne tienopirymidyny jako inhibitory kanału potasowego |
| WO2005067546A2 (en) | 2004-01-13 | 2005-07-28 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| AU2005254057B2 (en) | 2004-06-15 | 2011-02-17 | Isis Pharmaceuticals, Inc. | C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase |
| WO2006093518A2 (en) | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
| WO2006010568A2 (de) | 2004-07-23 | 2006-02-02 | Curacyte Discovery Gmbh | Substituierte pyrido [3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1 h,3h)-diones und -4(3h)-one sowie pyrido [3',2' :4,5] furo[3,2-d]pyrimidin -2,4(1 h,3h)-dione und -4(3h)-one zur verwendung als inhibitoren der tnf-allpha freisetzung |
| DE102005013621A1 (de) | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
| TWI498332B (zh) | 2006-04-26 | 2015-09-01 | Hoffmann La Roche | 作為pi3k抑制劑之嘧啶衍生物及相關製備方法、醫藥組合物、用途、套組及產物 |
| WO2008037607A1 (de) | 2006-09-25 | 2008-04-03 | Basf Se | Carbonylgruppen-enthaltende heterocyclische verbindungen und deren verwendung zur bekämpfung von phytopathogenen pilzen |
| ES2571028T3 (es) * | 2006-12-07 | 2016-05-23 | Genentech Inc | Compuestos inhibidores de fosfoinositida 3-cinasa y métodos de uso |
| EP2334380B1 (en) | 2008-05-30 | 2021-09-01 | Mitologics | Ant-ligands molecules and biological applications |
| AU2010203512C1 (en) * | 2009-01-08 | 2013-10-17 | Curis, Inc. | Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| UA109775C2 (xx) | 2009-10-29 | 2015-10-12 | N-вмісні гетероарильні похідні як інгібітори jak3-кінази | |
| AU2011239537A1 (en) * | 2010-04-16 | 2012-11-15 | Curis, Inc. | Treatment of cancers having K-ras mutations |
-
2012
- 2012-11-19 ES ES12795969.0T patent/ES2575143T3/es active Active
- 2012-11-19 CN CN201280057805.9A patent/CN104053661B/zh active Active
- 2012-11-19 EP EP12795969.0A patent/EP2782917B1/en active Active
- 2012-11-19 CA CA2855446A patent/CA2855446C/en active Active
- 2012-11-19 JP JP2014543517A patent/JP6206926B2/ja active Active
- 2012-11-19 IN IN4558CHN2014 patent/IN2014CN04558A/en unknown
- 2012-11-19 EP EP15196784.1A patent/EP3048106B1/en active Active
- 2012-11-19 MX MX2014006233A patent/MX355088B/es active IP Right Grant
- 2012-11-19 AU AU2012340869A patent/AU2012340869B2/en active Active
- 2012-11-19 WO PCT/US2012/065831 patent/WO2013078126A1/en not_active Ceased
-
2014
- 2014-05-12 IL IL232559A patent/IL232559B/en active IP Right Grant
- 2014-05-22 US US14/285,007 patent/US9604994B2/en active Active
-
2017
- 2017-01-26 US US15/417,191 patent/US10183950B2/en active Active
- 2017-06-02 AU AU2017203725A patent/AU2017203725B2/en active Active
-
2018
- 2018-12-06 US US16/212,582 patent/US10954251B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2782917B1 (en) | 2016-03-02 |
| IN2014CN04558A (https=) | 2015-09-18 |
| US20140323435A1 (en) | 2014-10-30 |
| EP2782917A1 (en) | 2014-10-01 |
| AU2017203725B2 (en) | 2019-02-28 |
| IL232559B (en) | 2018-04-30 |
| AU2017203725A1 (en) | 2017-06-22 |
| NZ625447A (en) | 2015-09-25 |
| US9604994B2 (en) | 2017-03-28 |
| JP6206926B2 (ja) | 2017-10-04 |
| HK1202529A1 (zh) | 2015-10-02 |
| US10183950B2 (en) | 2019-01-22 |
| CA2855446A1 (en) | 2013-05-30 |
| US20170158706A1 (en) | 2017-06-08 |
| EP3048106A1 (en) | 2016-07-27 |
| JP2014533728A (ja) | 2014-12-15 |
| MX2014006233A (es) | 2014-10-17 |
| CA2855446C (en) | 2021-04-20 |
| WO2013078126A1 (en) | 2013-05-30 |
| US20190106433A1 (en) | 2019-04-11 |
| CN104053661A (zh) | 2014-09-17 |
| AU2012340869B2 (en) | 2017-03-02 |
| IL232559A0 (en) | 2014-06-30 |
| MX355088B (es) | 2018-04-04 |
| AU2012340869A1 (en) | 2014-06-19 |
| CN104053661B (zh) | 2018-06-19 |
| EP3048106B1 (en) | 2019-11-06 |
| US10954251B2 (en) | 2021-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2575143T3 (es) | Inhibidores de tienopiridina de la proteína quinasa C atípica | |
| AU2019264475C1 (en) | Bcl-2 inhibitors | |
| AU2018256459B2 (en) | Indole AHR inhibitors and uses thereof | |
| ES2829636T3 (es) | Pirazolo[3,4-b]piridin-6-carboxamidas N-sulfoniladas y método de uso | |
| ES2575710T3 (es) | Derivados de pirrolopirimidina y purina | |
| AU2022371727A1 (en) | Nitrogen-containing tetracyclic compound, preparation method therefor, and medical use thereof | |
| AU2019356011B2 (en) | Fused pyrrolines which act as Ubiquitin-Specific Protease 30 (USP30) inhibitors | |
| BR112020003676A2 (pt) | compostos de pirazolopirimidinona e usos dos mesmos | |
| JP6199316B2 (ja) | １Ｈ−ピロロ［２，３−ｂ］ピリジン誘導体およびキナーゼ阻害剤としてのその使用 | |
| BR112020022006A2 (pt) | piridazinonas como inibidores de parp7 | |
| KR20230097015A (ko) | Mas-관련 G-단백질 수용체 X2의 조절제 및 관련 생성물 및 방법 | |
| BR112019004586A2 (pt) | derivados de pirazolopiridina como moduladores de hpk1 e usos dos mesmos para o tratamento de câncer | |
| EP4267553A1 (en) | Modulators of mas-related g-protein receptor x2 and related products and methods | |
| CA2754457A1 (en) | Quinoxaline compounds | |
| JP2019512535A (ja) | Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体 | |
| KR20160086404A (ko) | Mknk1 및 mknk2 억제제로서의 티에노피리미딘 | |
| CN121002021A (zh) | 三环杂环衍生物及其组合物和应用 | |
| EP3365346A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
| NZ625447B2 (en) | Thienopyrimidine inhibitors of atypical protein kinase c | |
| HK1202529B (en) | Thienopyrimidine inhibitors of atypical protein kinase c | |
| EA052513B1 (ru) | Соединения и их применение в качестве ингибиторов hdac6 | |
| OA16753A (en) | Pyrrolopyrimidine and purine derivatives. |